Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Preclinical Oncology Services (PRECOS) has entered into a partnership agreement to provide scientific data for Reliable Cancer Therapies' (RCT) research on complementary cancer therapies.
Subscribe to our email newsletter
The parntership allows PRECOS to validate RCT’s existing research using its validated patient relevant cancer models like in vitro 2D and 3D assays, in vivo therapeutic evaluations and post-study analyses.
Preclinical Oncology Services chairman Neil Rotherham said their advanced models challenge new therapeutic agents similar to the situation in the patient thereby providing clinically predictive data which they have applied to a broad spectrum of therapies including complementary therapies.